Malesci, member of Menarini Group: congresses with "zero impact ®" on the environement

Handbook for asmathic patients

The 15th A. Menarini Diagnostics web site – dedicated to the recently opened Swiss affiliate – has been published on line today

Exclusive European distribution rights for a random access system for the determination of a panel of 21 tests for the diagnosis of autoimmune diseases.

Otilonium Bromide maintains its efficacy even after treatment

ANT (A Non-profit Organisation for Cancer Patients) has awarded Menarini the Eubiosia prize for the excellence of the Mimosa Study.

Menarini is granted European rights to Adenuric®, innovative drug for chronic hyperuricaemia in gout.

Mimosa Project in collaboration with ANT against ovarian cancer